Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ACA, AgreementSM, allegedly, bioavailability, BLA, blind, breadth, breakthrough, broadly, bulk, constrain, contractor, convenience, conventional, coordinate, CRO, debarred, demographic, denied, disagree, dismissing, dispensing, dominance, double, drinibant, dropping, ease, elderly, encapsulate, entry, EU, fashion, filer, fire, furniture, GBP, GMT, hand, harbor, hard, implicit, imprisonment, improper, inconsistent, incremental, inhibit, insufficient, irritation, leasehold, levied, MMA, Modernization, Mortgage, nalmafene, novelty, nvestor, omission, outsourcing, Parliament, penalized, PERL, permission, pharmacy, PK, placebo, problem, proceed, progressed, promising, proof, PTAB, qualification, registry, remeasure, resume, RSU, satisfactorily, sham, shorter, shut, sooner, strict, stringent, surgical, sweeping, technique, toxicology, unfair, unintended, unlawful, usage, variability, variable, wholesale, withdrawn, withdrew
Removed:
assessing, beneficially, bingeing, bulimia, collective, compelling, concentration, counterparty, decreased, default, diagnosed, doubt, earn, exercisable, exert, explore, Floor, fluoxetine, forfeited, fundamental, hundred, improving, influencing, LLTP, location, negated, nervosa, obesity, pension, Premier, profile, psychiatric, purging, quotation, recognizing, removal, repayment, split, sum, Titan, treasurer, unexercised, unpaid, Vyvanse
Filing tables
Filing exhibits
Related press release
Associated OPNT transcripts
OPNT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-3 (File No. 333-220976) and Form- S-8 (File Nos. 333-221759 and 333-224239) of our report dated March 4, 2020 with respect to the audited consolidated financial statements of Opiant Pharmaceuticals, Inc. included in the Annual Report on Form 10 K for the year ended December 31, 2019.
/s/ MaloneBailey, LLP www.malonebailey.com
Houston, Texas
March 4, 2020